Review
Dopamine receptor pharmacology

https://doi.org/10.1016/0165-6147(94)90323-9Get rights and content

Abstract

Dopamine receptors are the primary targets in the treatment of schizophrenia, Parkinson's disease, and Huntington's chorea, and are discussed in this review by Philip Seeman and Hubert Van Tol. Improved therapy may be obtained by drugs that selectively target a particular subtype of dopamine receptor. Most antipsychotic drugs block D2 receptors in direct correlation to clinical potency, except clozapine, which prefers D4 receptors. D1 and D2 receptors can enhance each other's actions, possibly through subunits of the G proteins. In schizophrenia, the D2 and D3 receptor density is elevated by 10%, while the D4 receptor density is elevated by 600%. Therefore, D4 receptors may be a target for future antipsychotic drugs. While antipsychotics originally helped to discover dopamine receptors, the five cloned dopamine receptors are now facilitating the discovery of selective antipsychotic and antiparkinson drugs.

References (56)

  • D.R. Sibley et al.

    Trends Pharmacol. Sci.

    (1992)
  • P. Sokoloff et al.

    Biochem. Pharmacol.

    (1992)
  • H. Corrodi et al.

    Life Sci.

    (1967)
  • N-E. Andén et al.

    Eur. J. Pharmacol.

    (1970)
  • L.S. Pilowsky

    Lancet

    (1992)
  • T. Brücke

    Lancet

    (1992)
  • C.H. Miller et al.

    Prog. Neuro-Psychopharmacol. Biol. Psychiatr.

    (1992)
  • P. Seeman

    Eur. J. Pharmacol.-Mol. Pharmacol. Sect.

    (1992)
  • T. Nguyen

    Gene

    (1991)
  • M. Itokawa et al.

    Biochem. Biophys. Res. Commun.

    (1993)
  • Y. Nagai et al.

    Biochem. Biophys. Res. Commun.

    (1993)
  • L.A. Snyder et al.

    Biochem. Biophys. Res. Commun.

    (1991)
  • M. Catalano et al.

    Biol. Psychiatry

    (1993)
  • B. Giros et al.

    Biochem. Biophys. Res. Commun.

    (1991)
  • S. Pagliusi et al.

    Biochem. Biophys. Res. Commun.

    (1993)
  • C.S. Fishburn et al.

    J. Biol. Chem.

    (1993)
  • J. De Keyser

    Neurochem. Int.

    (1993)
  • B.F. O'Dowd

    J. Neurochem.

    (1993)
  • A. Carlsson et al.

    Acta Pharmacol. Toxicol.

    (1963)
  • P. Seeman et al.
  • P.F. Spano et al.

    Adv. Biochem. Psychopharmacol.

    (1978)
  • J.W. Kebabian et al.

    Nature

    (1979)
  • H.H.M. Van Tol

    Nature

    (1991)
  • H.H.M. Van Tol

    Nature

    (1992)
  • J.B. Lichter

    Hum. Mol. Genet.

    (1993)
  • P. Seeman et al.

    Curr. Opin. Neurol. Neurosurg.

    (1993)
  • P. Seeman et al.

    Nature

    (1993)
  • P. Seeman

    Neuropsychopharmacology

    (1992)
  • Cited by (0)

    View full text